Analysis on clinical distribution and drug resistance of Pseudomonas aeruginosa in our hospital during 2010-2013
10.3969/j.issn.1673-4130.2015.07.019
- VernacularTitle:2010～2013年本院铜绿假单胞菌的临床分布和耐药性分析
- Author:
Min WU
;
Lixia ZHANG
;
Li ZHANG
;
Ranran FENG
- Publication Type:Journal Article
- Keywords:
pseudomonas aeruginosa;
resistance rate;
antibacterial agents;
nosocomial infection
- From:
International Journal of Laboratory Medicine
2015;(7):908-910
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical distribution and drug resistance of Pseudomonas aeruginosa (PAE) isolated from the samples to provide the guidance for the clinician′s medication .Methods The VITEC‐2 Compact system automatic bacterial i‐dentification and drug susceptibility analyzer was adopted to identify the isolated bacteria and conduct the drug sensitivity test ,the data were processed by the WHONET 5 .6 software .The PAE detection situation from the submitted specimens ,source and drug resistance were performed the retrospective analysis .Results The detected PAE strains were mainly isolated from the lower respir‐atory tract specimens ,accounting for 85 % of the submitted specimens ;the resistance rate to aztreonam ,amikacin ,ciprofloxacin , meropenem ,piperacillin/tazobactam ,piperacillin ,gentamicin ,cefepime ,ceftazidime ,tobramycin ,imipenem and levofloxacin showed the declining trend year by year .Except the resistant rate of aztreonam was 28 .2% in 2013 ,which of other antibiotics were at about 10% .Conclusion PAE infection is mainly in the respiratory tract ,its rug resistances should be timely and reasonably monitored to provide the basis for clinical medication .
